FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.2  |  FHIR Version n/a  User: [n/a]

1454601000168109: cobicistat 150 mg + darunavir 800 mg + emtricitabine 200 mg + tenofovir alafenamide 10 mg tablet (medicinal product unit of use)

Status: current, Defined. Date: 31-Mar 2020. Module: Australian Medicines Terminology module

Descriptions:

Id Description Lang Type Status Case? Module
4355951000168115 cobicistat 150 mg + darunavir 800 mg + emtricitabine 200 mg + tenofovir alafenamide 10 mg tablet (medicinal product unit of use) en Fully specified name Active Case sensitive Australian Medicines Terminology module
4355961000168118 darunavir 800 mg + cobicistat 150 mg + emtricitabine 200 mg + tenofovir alafenamide 10 mg tablet en Synonym Active Case sensitive Australian Medicines Terminology module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
darunavir 800 mg + cobicistat 150 mg + emtricitabine 200 mg + tenofovir alafenamide 10 mg tablet Is a darunavir + cobicistat + emtricitabine + tenofovir alafenamide true Inferred relationship Some
darunavir 800 mg + cobicistat 150 mg + emtricitabine 200 mg + tenofovir alafenamide 10 mg tablet Is a darunavir 800 mg + cobicistat 150 mg tablet true Inferred relationship Some
darunavir 800 mg + cobicistat 150 mg + emtricitabine 200 mg + tenofovir alafenamide 10 mg tablet Is a emtricitabine 200 mg + tenofovir alafenamide 10 mg tablet true Inferred relationship Some
darunavir 800 mg + cobicistat 150 mg + emtricitabine 200 mg + tenofovir alafenamide 10 mg tablet has manufactured dose form tablet true Inferred relationship Some
darunavir 800 mg + cobicistat 150 mg + emtricitabine 200 mg + tenofovir alafenamide 10 mg tablet has Australian BoSS darunavir true Inferred relationship Some 1495319174
darunavir 800 mg + cobicistat 150 mg + emtricitabine 200 mg + tenofovir alafenamide 10 mg tablet has intended active ingredient darunavir true Inferred relationship Some 1495319174
darunavir 800 mg + cobicistat 150 mg + emtricitabine 200 mg + tenofovir alafenamide 10 mg tablet has Australian BoSS emtricitabine true Inferred relationship Some 780210174
darunavir 800 mg + cobicistat 150 mg + emtricitabine 200 mg + tenofovir alafenamide 10 mg tablet has intended active ingredient emtricitabine true Inferred relationship Some 780210174
darunavir 800 mg + cobicistat 150 mg + emtricitabine 200 mg + tenofovir alafenamide 10 mg tablet has intended active ingredient cobicistat true Inferred relationship Some 1537477766
darunavir 800 mg + cobicistat 150 mg + emtricitabine 200 mg + tenofovir alafenamide 10 mg tablet has Australian BoSS cobicistat true Inferred relationship Some 1537477766
darunavir 800 mg + cobicistat 150 mg + emtricitabine 200 mg + tenofovir alafenamide 10 mg tablet has unit of use tablet true Inferred relationship Some 1998929224
darunavir 800 mg + cobicistat 150 mg + emtricitabine 200 mg + tenofovir alafenamide 10 mg tablet has intended active ingredient tenofovir alafenamide true Inferred relationship Some 1139134513
darunavir 800 mg + cobicistat 150 mg + emtricitabine 200 mg + tenofovir alafenamide 10 mg tablet has Australian BoSS tenofovir alafenamide true Inferred relationship Some 1139134513
Inbound Relationships Type Active Source Characteristic Refinability Group
Symtuza tablet Is a True darunavir 800 mg + cobicistat 150 mg + emtricitabine 200 mg + tenofovir alafenamide 10 mg tablet Inferred relationship Some
darunavir 800 mg + cobicistat 150 mg + emtricitabine 200 mg + tenofovir alafenamide 10 mg tablet, 30 has MPUU True darunavir 800 mg + cobicistat 150 mg + emtricitabine 200 mg + tenofovir alafenamide 10 mg tablet Inferred relationship Some 915198206

Reference Sets

List of Excluded Medicinal Items reference set

Medicinal product unit of use reference set

Back to Start